Connaissances Accueil Santé humaine Connaissances All Avis Exposés Science populaire Entretiens Filtrer Therapeutic areas COVID-19 Santé digestive Apply Accueil Santé humaine Connaissances Mechanism of action of an adjuvanted protein vaccine based on the RBD from SARS-CoV-2 Spike protein Accueil Santé humaine Connaissances Safety and Immunogenicity of PHH-1V Booster Against SARS-CoV-2 Variants, Including Omicron Subvariants: Results from a Phase IIb Open-Label Extension Study Accueil Santé humaine Connaissances Rethinking optimal immunogens to face SARS-CoV-2. Evolution through vaccination Accueil Santé humaine Connaissances Antibody and B-cell responses to PHH-1V81 XBB.1.16-adapted SARS-CoV-2 booster vaccination are associated with variant neutralization Accueil Santé humaine Connaissances Immunogenicity and safety of PHH-1V COVID-19 vaccine as a heterologus booster in adolescents Accueil Santé humaine Connaissances 34th ECCMID Integrated Symposium, 2024: COVID-19 booster immunization Accueil Santé humaine Connaissances Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Accueil Santé humaine Connaissances Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 Accueil Santé humaine Connaissances Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Charger plus
